An Amgen disclosure of a large stake in Neumora Therapeutics indicated the value of its investment in the biotech, which ...
this bull market crashed — and freight intermediaries have had to cull staff. The post Coyote Logistics restructures, lays off unspecified number appeared first on FreightWaves.
Amgen today announced data from the final analysis ... Annual Meeting being held in Amsterdam. In the off-treatment extension period, olpasiran showed a lasting effect on Lp(a) reduction nearly ...
The Federal Trade Commission announced Friday it had reached a settlement with Amgen Inc. over the biopharmaceutical firm’s $27.8 billion acquisition of Horizon Therapeutics, after the agency ...
The Federal Trade Commission will allow pharmaceutical giant Amgen to move ahead with its acquisition of Horizon Therapeutics, averting a trial set for September. In a news release Friday ...
Cybersecurity giant Malwarebytes this week laid off 100 employees as it prepares for a major restructuring that will see the business split into two, TechCrunch has learned. The layoffs come ...
Amgen AMGN is one of the biggest biotech companies in the world, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health and nephrology ...
The Federal Trade Commission will allow pharmaceutical giant Amgen to move ahead with its acquisition of Horizon Therapeutics, averting a trial set for September. In a news release Friday ...
Amgen could report great quarterly results with revenue, operating income and EPS growing with a solid pace. The stock is undervalued in my opinion and Amgen could be seen as a good investment ...
Google parent Alphabet is laying off employees from its global recruiting team as the tech giant continues to slow hiring, it said on Wednesday. The company's decision to let go of a few hundred ...
Amgen’s $28 billion purchase of Horizon Therapeutics can now proceed following a settlement with the Federal Trade Commission, but with safeguards designed to preserve competition in two rare ...
The Federal Trade Commission has reached a deal with drug giant Amgen to allow the company's $27.8 billion purchase of Horizon Therapeutics to move forward. But the agreement prohibits Amgen ...
